Fuse H - Search Results

1

Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor.

Yamamoto T, Sato N, Sekine Y, Yumioka T, Imoto S, Junicho A, Fuse H, Matsuda T. Yamamoto T, et al. Among authors: fuse h. Biochem Biophys Res Commun. 2003 Jun 27;306(2):610-5. doi: 10.1016/s0006-291x(03)01026-x. Biochem Biophys Res Commun. 2003. PMID: 12804609 Free article.

2

Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3.

Sato N, Yamamoto T, Sekine Y, Yumioka T, Junicho A, Fuse H, Matsuda T. Sato N, et al. Among authors: fuse h. Biochem Biophys Res Commun. 2003 Jan 24;300(4):847-52. doi: 10.1016/s0006-291x(02)02941-8. Biochem Biophys Res Commun. 2003. PMID: 12559950 Free article.

3

Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR).

Nagakawa O, Murata J, Junicho A, Matsuda T, Fujiuchi Y, Fuse H, Saiki I. Nagakawa O, et al. Among authors: fuse h. Cancer Lett. 2002 Feb 8;176(1):93-9. doi: 10.1016/s0304-3835(01)00737-6. Cancer Lett. 2002. PMID: 11790458

4

Differential expression of integrin subunits in DU-145/AR prostate cancer cells.

Nagakawa O, Akashi T, Hayakawa Y, Junicho A, Koizumi K, Fujiuchi Y, Furuya Y, Matsuda T, Fuse H, Saiki I. Nagakawa O, et al. Among authors: fuse h. Oncol Rep. 2004 Oct;12(4):837-41. Oncol Rep. 2004. PMID: 15375509

5

Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.

Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I. Nagakawa O, et al. Among authors: fuse h. Oncol Rep. 2005 Jun;13(6):1217-21. Oncol Rep. 2005. PMID: 15870945

6

Serum interleukin-11 in patients with benign prostatic hyperplasia and prostate cancer.

Furuya Y, Nishio R, Junicho A, Nagakawa O, Fuse H. Furuya Y, et al. Among authors: fuse h. Int Urol Nephrol. 2005;37(1):69-71. doi: 10.1007/s11255-004-6086-1. Int Urol Nephrol. 2005. PMID: 16132763

7

Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer.

Nagakawa O, Yamagishi T, Fujiuchi Y, Junicho A, Akashi T, Nagaike K, Fuse H. Nagakawa O, et al. Among authors: fuse h. Eur Urol. 2005 Oct;48(4):686-90. doi: 10.1016/j.eururo.2005.05.020. Eur Urol. 2005. PMID: 16005141

8

[Androgen receptor].

Komiya A, Watanabe A, Yasuda K, Fuse H. Komiya A, et al. Among authors: fuse h. Nihon Rinsho. 2010 Jul;68 Suppl 7:505-10. Nihon Rinsho. 2010. PMID: 20960820 Japanese. No abstract available.

9

[Basic mechanisms of androgen-independent growth in the prostate cancer].

Komiya A, Yasuda K, Watanabe A, Fuse H. Komiya A, et al. Among authors: fuse h. Nihon Rinsho. 2011 Jun;69 Suppl 5:96-103. Nihon Rinsho. 2011. PMID: 22207950 Review. Japanese. No abstract available.

10

The effect of eicosapentaenoic acid on prostate-specific antigen.

Hamazaki K, Higashihara E, Terachi T, Takada H, Matsuda T, Kawakita M, Fuse H, Hamazaki T, Kameyama S, Masai M, Chiba Y, Tokunaga M, Furuya Y, Okegawa T, Murota T, Kawa G, Itomura M. Hamazaki K, et al. Among authors: fuse h. In Vivo. 2006 May-Jun;20(3):397-401. In Vivo. 2006. PMID: 16724678 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters